Comorbidities in Patients with Psoriasis

被引:153
|
作者
Gottlieb, Alice B. [1 ]
Dann, Frank [2 ]
机构
[1] Tufts Med Ctr, Boston, MA 02111 USA
[2] VA Med Ctr, Long Beach, CA USA
来源
AMERICAN JOURNAL OF MEDICINE | 2009年 / 122卷 / 12期
关键词
Cardiovascular disease; Metabolic syndrome; Psoriasis; Psoriatic arthritis comorbidities; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTORS; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; METABOLIC SYNDROME; MYOCARDIAL-INFARCTION; CLINICAL-FEATURES; VASCULAR-DISEASES; MALIGNANT-TUMORS; LIPID PROFILE;
D O I
10.1016/j.amjmed.2009.06.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Psoriasis is a common chronic inflammatory disease that is associated with serious comorbidities, including psoriatic arthritis, reduced quality of life, depression, malignancy, and cardiovascular comorbidities. Patients with psoriasis have been shown to have an increased incidence of metabolic syndrome and cardiovascular disease compared with the general population. The chronic inflammatory nature of psoriasis has been suggested to be a contributing and potentially independent risk factor for the development of cardiovascular comorbidities. Understanding the interrelationship between these conditions is important for the management of psoriasis and the associated comorbidities. This review will focus on the range of comorbidities associated with psoriasis, with emphasis on cardiometabolic conditions and the aim of encouraging primary care physicians to screen psoriatic patients for cardiometabolic disorders and risk factors. (C) 2009 Elsevier Inc. All rights reserved. The American Journal of Medicine (2009) 122, 1150.e1-1150.e9
引用
收藏
页码:1150.e1 / 1150.e9
页数:9
相关论文
共 50 条
  • [41] A retrospective analysis of comorbidities in patients with psoriasis at a single centre
    Huang, Rui
    Zhuang, Yi
    Chang, Yuan
    Li, Lin-Feng
    Xu, Hong -Jun
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2024, 41 (02): : 164 - 172
  • [42] Comorbidities significantly impact patients' preferences for psoriasis treatments
    Schmieder, Astrid
    Schaarschmidt, Marthe-Lisa
    Umar, Nasir
    Terris, Darcy D.
    Goebeler, Matthias
    Goerdt, Sergij
    Peitsch, Wiebke K.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (03) : 363 - 372
  • [43] Management of moderate to severe psoriasis in patients with metabolic comorbidities
    Gisondi, Paolo
    Galvan, Arturo
    Idolazzi, Luca
    Girolomoni, Giampiero
    FRONTIERS IN MEDICINE, 2015, 2
  • [44] Psoriasis and Its Comorbidities
    Onumah, Neh
    Kircik, Leon H.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (05) : S5 - S10
  • [45] Psoriasis: comorbidities and associations
    Farley, E.
    Menter, A.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2011, 146 (01): : 9 - 15
  • [46] Psoriasis and comorbidities in children
    Caroppo, F.
    Fortina, A. Belloni
    ARCHIVES DE PEDIATRIE, 2019, 26 (04): : 247 - 247
  • [47] Epidemiology of comorbidities in psoriasis
    Naldi, Luigi
    Mercuri, Santo Raffaele
    DERMATOLOGIC THERAPY, 2010, 23 (02) : 114 - 118
  • [48] Comorbidities in people with psoriasis
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (03) : e31 - e31
  • [49] Psoriasis: new comorbidities
    Machado-Pinto, Jackson
    Diniz, Michelle dos Santos
    Bavoso, Nadia Couto
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2016, 91 (01) : 8 - 14
  • [50] Psoriasis and Metabolic Comorbidities
    Gisondi, Paolo
    CLINICAL DRUG INVESTIGATION, 2013, 33 : S77 - S78